In this episode, Mirianas Chachisvilis, Ph.D., CEO & CTO, Veriskin, Inc., discusses building and scaling a medical device company, navigating clinical trials and FDA pathways, and creating a cost effective model to improve early skin cancer detection and reduce unnecessary healthcare spending.
Podcast: Play in new window | Download